Chronic myeloid leukemia (CML) is a myeloproliferative disease characterized by the presence of chromosomal abnormality leading to the aberrant Abelson oncogene (Abl)-breakpoint cluster region (Bcr) gene fusion, which encodes for the Bcr-Abl tyrosine kinase. Here, BCR is linked to myeloproliferative disorder.